Gennova Bio
Pune, India· Est.
Indian biotech delivering a portfolio of recombinant therapeutics and mRNA vaccines through innovative, scalable manufacturing.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian biotech delivering a portfolio of recombinant therapeutics and mRNA vaccines through innovative, scalable manufacturing.
CardiovascularNeurologyNephrologyOncologyInfectious Diseases
Technology Platform
Recombinant DNA expression (bacterial, yeast, mammalian) combined with perfusion‑based continuous manufacturing and AI‑guided process optimization; includes an mRNA vaccine platform.
Opportunities
Expansion of its mRNA vaccine platform and scaling AI‑driven manufacturing could open access to high‑value regulated markets and emerging infectious disease pipelines.
Risk Factors
Regulatory hurdles in global markets, competition from larger biotech firms, and substantial capital requirements for late‑stage clinical development and commercial scaling.
Competitive Landscape
Competes with Indian biosimilar leaders (Biocon, Serum Institute) and global biotech firms in mRNA and thrombolytic spaces; differentiation lies in its patented continuous manufacturing process and AI integration.